Boston, MA 05/08/2014 (wallstreetpr) – The drug developer Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) has agreed to be acquired for $658 million in a transaction that […]
Boston, MA 04/28/2014 (wallstreetpr) – Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) has carried out a public offering of 7.67 million shares of its common stock. This includes […]
Boston, MA 02/19/2014 (wallstreetpr) – Chelsea Therapeutics International Ltd (NASDAQ:CHTP) received the best news it could have wished for,with the approval of its Northera drug that […]
Boston, MA 07/24/2013 (wallstreetpr) – Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) announced that New Drug Application (NDA) resubmission seeking approval to market NORTHERA™ (droxidopa), got approval from […]
